Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pCG-Hc∆18-AA-IL-13
(Plasmid #86171)

Ordering

Item Catalog # Description Quantity Price (USD)
Plasmid 86171 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.

Backbone

  • Vector backbone
    pCG
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Measles virus H glycoprotein fused to IL-13
  • Mutation
    Y463A, R515A
  • Tag / Fusion Protein
    • 6x His (C terminal on insert)

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    Dr. Andrea Maisner, Philipps University of Marburg, 35043 Marburg Germany Dr. Evanthia Galanis, Mayo Clinic, Rochester, MN 55905

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCG-Hc∆18-AA-IL-13 was a gift from Jakob Reiser (Addgene plasmid # 86171 ; http://n2t.net/addgene:86171 ; RRID:Addgene_86171)
  • For your References section:

    Specific targeting of human interleukin (IL)-13 receptor alpha2-positive cells with lentiviral vectors displaying IL-13. Ou W, Marino MP, Suzuki A, Joshi B, Husain SR, Maisner A, Galanis E, Puri RK, Reiser J. Hum Gene Ther Methods. 2012 Apr;23(2):137-47. Epub 2012 May 21. 10.1089/hgtb.2012.054 PubMed 22612657